Abstract CT188: A phase Ib study of sapacitabine (sapa) and olaparib (ola) in patients (pts) with <i>BRCA1/2-</i>mutated (<i>BRCA1/2</i>m) metastatic breast cancer (MBC)

Authors: Filipa Lynce, Noah Graham, Bose S. Kochupurakkal, Huy Nguyen, Philip D. Poorvu, Victoria Attaya, Raechel Davis, Kavita Garg, Lee P. Lim, Mark Li, Cloud P. Paweletz, Nabihah Tayob, Geoffrey I. Shapiro, Sara M. Tolaney

Published: 2023-04-14

DOI: 10.1158/1538-7445.am2023-ct188

Source: Full article